secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001104659-24-008229
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharma enters $8M equity purchase agreement with Alumni Capital, with $4M minimum purchase commitment
--------------------------------------------------------------------------------

- Agreement allows Quoin to sell up to $8M of ADSs to Alumni Capital at discounts of 2% to 10% to market.
- Minimum purchase of $4M required during the 90-day commitment period, extendable by 90 days.
- Per-purchase limit typically $500k; floor price $1.00; commitment fee up to $240k in ADSs.
- Shareholder approval must be obtained by April 30, 2024; else Quoin may terminate agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/0001104659-24-008229-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924008229/tm244426d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-008229

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer